Clinical Characterization of Parkinson's Disease Patients With Cognitive Impairment.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

1. Risk factors for mild cognitive impairment in Parkinson disease: a systematic review and meta-analysis.Molecular and cellular biochemistry · 2026
   Pooled it
2. The effect of different exercise training modes on improving quality of life in patients with Parkinson's disease: a network analysis.Frontiers in neurology · 2025
   Pooled it
3. Hyposmia as a predictor of cognitive decline in long-term Parkinson's disease with dementia: a multicenter study in China.Journal of neural transmission (Vienna, Austria : 1996) · 2026
   Observational
4. The Effect of Deep Brain Stimulation on Sleep and Cognition in Patients With Parkinson's Disease.Journal of sleep research · 2026
   Article
5. Associations between Thyroid Hormones and Cognitive Impairment in Patients with Parkinson's Disease.eNeuro · 2024
   Article
6. Mitochondrial Aconitase and Its Contribution to the Pathogenesis of Neurodegenerative Diseases.International journal of molecular sciences · 2024
   Review
7. Effects of Rehabilitation Training on Cognitive Function in Parkinson's Disease with Subjective Cognitive Decline.Neuropsychiatric disease and treatment · 2024
   Article
8. Mild cognitive impairment in multiple system atrophy: a brain network disorder.Journal of neural transmission (Vienna, Austria : 1996) · 2023
   Review
9. Cognitive Correlates of Visual and Minor Hallucinations in Parkinson's Disease.The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques · 2023
   Article
10. How sleep quality affects activities of daily living in Parkinson's disease: the mediating role of disease severity and the moderating role of cognition.Frontiers in aging neuroscience · 2023
    Article
11. Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson's disease.Scientific reports · 2022
    Article
12. Mitochondrial Calcium: Effects of Its Imbalance in Disease.Antioxidants (Basel, Switzerland) · 2022
    Review
13. Urinary Tract Infection in Parkinson's Disease.Journal of Parkinson's disease · 2022
    Review
14. Disease progression in Parkinson's disease patients with subjective cognitive complaint.Annals of clinical and translational neurology · 2021
    Article
15. Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling.Acta neuropathologica communications · 2021
    Review
16. Mitochondria-Plasma Membrane Contact Sites: Emerging Regulators of Mitochondrial Form and Function.Contact (Thousand Oaks (Ventura County, Calif.))
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 3 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as